BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2519931)

  • 1. Anti-idiotypic tumor vaccines.
    Hellström KE; Hellström I
    Int Rev Immunol; 1989; 4(4):337-46. PubMed ID: 2519931
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiotypic responses induced by tumor: an autocrine network.
    Köhler H; Raychaudhuri S; Chen JJ; Saeki Y
    Int Rev Immunol; 1989; 4(4):311-20. PubMed ID: 2535274
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-idiotypic monoclonal antibody cancer vaccines.
    Chapman PB
    Semin Cancer Biol; 1995 Dec; 6(6):367-74. PubMed ID: 8938275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines, and anti-idiotypes.
    Hellström KE; Hellström I
    Targeted Diagn Ther; 1989; 2():1-39. PubMed ID: 2519542
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 6. Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.
    Ferrone S
    Ann N Y Acad Sci; 1993 Aug; 690():214-24. PubMed ID: 8368740
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-idiotype vaccine against cancer.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-associated tumor antigens as targets for immunotherapy.
    Hellström KE; Hellström I
    FASEB J; 1989 Apr; 3(6):1715-22. PubMed ID: 2649402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibilities for active immunotherapy of human cancer.
    Hellström KE; Hellström I
    Cancer Invest; 1992; 10(4):285-93. PubMed ID: 1378351
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
    Wang X; Luo W; Foon KA; Ferrone S
    Cancer Chemother Biol Response Modif; 2001; 19():309-26. PubMed ID: 11686020
    [No Abstract]   [Full Text] [Related]  

  • 11. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
    Ferrone S; Kageshita T; Hirai S
    J Dermatol; 1993 Sep; 20(9):533-9. PubMed ID: 8227707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for immunotherapy of cancer.
    Melief CJ; Toes RE; Medema JP; van der Burg SH; Ossendorp F; Offringa R
    Adv Immunol; 2000; 75():235-82. PubMed ID: 10879286
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibodies for cancer immunotherapy.
    Weiner LM; Dhodapkar MV; Ferrone S
    Lancet; 2009 Mar; 373(9668):1033-40. PubMed ID: 19304016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines in lymphoma.
    Levy R
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
    [No Abstract]   [Full Text] [Related]  

  • 15. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    Int Rev Immunol; 1989; 4(4):251-70. PubMed ID: 2519929
    [No Abstract]   [Full Text] [Related]  

  • 17. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
    Castello G; D'Alessio V
    Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGcGM3 ganglioside: a privileged target for cancer vaccines.
    Fernandez LE; Gabri MR; Guthmann MD; Gomez RE; Gold S; Fainboim L; Gomez DE; Alonso DF
    Clin Dev Immunol; 2010; 2010():814397. PubMed ID: 21048926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
    Kosugi A; Fujiwara H; Hamaoka T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody therapy of cancer.
    DiMaggio JJ; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1990; 11():177-203. PubMed ID: 2223394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.